IMMUcan publication identifies predictors of chemo-immunotherapy response…
IMMUcan publication identifies predictors of chemo-immunotherapy response in advanced [...]
IMMUcan publication identifies predictors of chemo-immunotherapy response in advanced [...]
Final results of ARCAGEN – an EORTC-SPECTA and EURACAN initiative [...]
Brussels, Belgium, 15 July 2026. A recent study published [...]
Minimal Residual Disease Assessment (MRD): New study explores whether a [...]
We are thrilled to announce that as of October 30th, [...]
Radon, a radioactive gas that can accumulate inside homes, is [...]
The IMMUcan project has successfully reached a major milestone by [...]
The EORTC 1920 BIORADON team is pleased to announce that [...]
We are thrilled to announce that a major milestone was [...]
We are happy to announce that we finished patient recruitment [...]